Supreme Court: Generic drugmaker may sue over brand patent

May 1, 2012

The U.S. Supreme Court has ruled that a generic drugmaker may challenge a brand-name rival over the scope of its patent, providing a legal remedy for generic manufacturers that believe unfair patents are keeping them from the market. (American Medical News)

Posted by Bioethics Pundit

Posted in Biotech, News, Public Policy

Recommended Reading